Connect Biopharma (CNTB) vs RenovoRx (RNXT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
RenovoRx (RNXT) has outperformed Connect Biopharma (CNTB) over the past year, gaining 12.3% versus a loss of 46.9%. Over five years, RNXT leads with a -77.1% price change compared with -94.5% for CNTB. RenovoRx is the larger company by market cap ($61.8 million vs $59.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTB | RNXT |
|---|---|---|
| Share price | $0.9447 | $1.37 |
| Market cap | $59.49M | $61.83M |
| 1-day change | +4.34% | -1.44% |
| YTD return | -66.50% | +63.10% |
| 1-year return | -46.93% | +12.30% |
| 5-year return | -94.50% | -77.09% |
| EPS (TTM) | $-1.25 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.82 | $2.59 |
| 52-week low | $0.85 | $0.701 |
| Distance from 52-week high | -75.27% | -47.10% |
| Average volume | 3.82M | 753.57K |
| Shares outstanding | 62.97M | 45.13M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RNXT has outperformed CNTB by 59.2 percentage points over the past year.
CNTB vs RNXT FAQ
Which is bigger, Connect Biopharma or RenovoRx?
RenovoRx (RNXT) is larger, with a market capitalization of $61.83M compared with $59.49M for Connect Biopharma (CNTB).
Which stock has performed better over the past year, CNTB or RNXT?
RNXT returned +12.30% over the past 12 months, compared with -46.93% for CNTB (price return, excluding dividends). Past performance does not predict future results.
Are Connect Biopharma and RenovoRx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.